Evidence map›Paper›PMID 27338369›Full record

ReviewInternational journal of molecular sciences2016

RNA Secondary Structure Modulates FMRP's Bi-Functional Role in the MicroRNA Pathway.

Phillip Kenny, Stephanie Ceman

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Unwinding the roles of RNA helicase MOV10.Wiley interdisciplinary reviews. RNA · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Of Men and Mice: Modeling the Fragile X Syndrome.Frontiers in molecular neuroscience · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Phillip KennyCell and Developmental Biology, University of Illinois-Urbana Champaign, Urbana, IL 61801, USA. pjkenny2@illinois.edu.
Stephanie CemanCell and Developmental Biology, University of Illinois-Urbana Champaign, Urbana, IL 61801, USA. sceman@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

Dynamic regulation of translation by fragile X mental retardation proteinR01MH093661 · NIMH · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CEMAN, STEPHANIE · 2012 to 2016
$1.8M
NIMH NIH HHS R01 MH093661
6 · The paper itself

Abstract

MicroRNAs act by post-transcriptionally regulating the gene expression of 30%-60% of mammalian genomes. MicroRNAs are key regulators in all cellular processes, though the mechanism by which the cell activates or represses microRNA-mediated translational regulation is poorly understood. In this review, we discuss the RNA binding protein Fragile X Mental Retardation Protein (FMRP) and its role in microRNA-mediated translational regulation. Historically, FMRP is known to function as a translational suppressor. However, emerging data suggests that FMRP has both an agonistic and antagonistic role in regulating microRNA-mediated translational suppression. This bi-functional role is dependent on FMRP's interaction with the RNA helicase Moloney leukemia virus 10 (MOV10), which modifies the structural landscape of bound mRNA, therefore facilitating or inhibiting its association with the RNA-Induced Silencing Complex.

Indexed as

G-QuadruplexesAnimalsFragile X Messenger Ribonucleoprotein 1HumansMicroRNAsRNA HelicasesFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1MicroRNAsRNA HelicasesFMRPG-QuadruplexmicroRNAMOV10RNA binding proteinssecondary structure

Identifiers

PMID27338369
PMCPMC4926514
OpenAlexW2460454199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.